Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
Therapy Name | Fenebrutinib |
Synonyms | |
Therapy Description |
Fenebrutinib (GDC-0853) is a small molecule inhibitor of BTK, including BTK C481S, which may result in reduced BTK activity, increased cytotoxicity, and antitumor activity (PMID: 30018078, PMID: 29560128). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
Fenebrutinib | GDC-0853 | BTK inhibitor 36 | Fenebrutinib (GDC-0853) is a small molecule inhibitor of BTK, including BTK C481S, which may result in reduced BTK activity, increased cytotoxicity, and antitumor activity (PMID: 30018078, PMID: 29560128). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|